Belgium vs Netherlands: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
Netherlands
270
in 2021
Belgium rank
86th
Netherlands rank
88th
The number of people with susceptibility test result for rifampicin over time
- Belgium
- Netherlands
How they compare
Belgium currently reports 377 against 270 in Netherlands, a difference of 107.
That makes Belgium's figure about 1.4 times Netherlands's.
Across all 5 years both countries report, Belgium has been ahead every year.
Belgium ranks 86th and Netherlands ranks 88th of 155 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 322.33 | 107.67 | Belgium |
| 2020s | 348.5 | 257 | 91.5 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or Netherlands?
- Belgium, at 377 against 270 in Netherlands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and Netherlands?
- 107, with Belgium ahead.
- How many years of comparable data are there for Belgium and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and Netherlands ranks 88th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.